HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anosmia: A Clinical Indicator of COVID-19 Reinfection.

Abstract
COVID-19, an ongoing world pandemic, is caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Many organizations have recognized that COVID-19 patients may have sudden loss of smell or taste and have included these symptoms in their diagnostic guidelines. However, the occurrence of anosmia and dysgeusia in COVID-19 reinfection is yet to be ascertained.
AuthorsAvani Jain, Jasleen Kaur, A K Rai, A K Pandey
JournalEar, nose, & throat journal (Ear Nose Throat J) Vol. 100 Issue 2_suppl Pg. 180S-181S (Apr 2021) ISSN: 1942-7522 [Electronic] United States
PMID33295221 (Publication Type: Case Reports, Letter)
Topics
  • Anosmia (etiology, physiopathology)
  • COVID-19 (complications, diagnosis, physiopathology)
  • COVID-19 Nucleic Acid Testing
  • Female
  • Humans
  • Reinfection (diagnosis, etiology, physiopathology)
  • SARS-CoV-2
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: